ALTA

ALTA

Condividi

ALTA Ricerca e Sviluppo in Biotecnologie is a service-provider company specialized in developing and managing scientific research projects financed by the European Commission and Italian Public Authorities. ALTA provides support and consultancy services for scientists and researchers at universities, in businesses and research institutes from the idea to project implementation finding the proper s

GLYTUNES: Call for applications for Early Stage Researchers for 14 Doctoral (PhD) Training Positions in Glycosciences and Glyco-Immunology 08/02/2021

Do you want to be part of a new generation of creative, entrepreneurial and innovative researchers? Do you wish to be trained to face current and future challenges? do you enjoy networking and knowing different cultures? GLYTUNES call is right for you!

GLYTUNES: Call for applications for Early Stage Researchers for 14 Doctoral (PhD) Training Positions in Glycosciences and Glyco-Immunology GLYTUNES is an Innovative Training Network (ITN) funded by the European Union Horizon 2020 Programme. GLYTUNES represents a novel, pioneering platform for understanding and exploiting the Siglecs-glycans cross-talk by harnessing the synergy of combining chemical to biological, biophysical, immunolog...

HERACLES 26/06/2018

The burden of CE in Eastern Europe (ultrasound surveys)

Prevalence of abdominal cystic echinococcosis in rural Bulgaria, Romania and Turkey

For further information, visit HERACLES website:

HERACLES Heracles - Cystic Echinococcosis

03/08/2017

PROJECTS APPROVED IN THE 2016-2017 CALL - HORIZON 2020

Health, demographic change and well-being - Personalised medicine - Clinical research on regenerative medicine:

- HIPGEN
Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
(Berlin-Brandenburg Center for Regenerative Therapies BCRT, Charité-Universitätsmedizin Berlin)

03/08/2017

LIVERHOPE project

Simvastatin and Rifaximin as new therapy for patients with decompensated cirrhosis

www.liverhope-h2020.eu

03/08/2017

PACE project

A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

www.pace-h2020.eu

Vuoi che la tua azienda sia il Palestra più quotato a Siena?
Clicca qui per richiedere la tua inserzione sponsorizzata.

Telefono

Indirizzo


Via Fiorentina 151
Siena
53100